Chronic pain and continuity of analgesic treatment during the COVID-19 pandemic.
Luis Fernando Valladales-RestrepoAndrés Gaviria-MendozaManuel Enrique Machado-DuqueJulio Andrés Prado-EcheverryJorge Luis Cortés-NavarroJorge Enrique Machado-AlbaPublished in: Pain practice : the official journal of World Institute of Pain (2022)
The pharmacological management of patients with chronic pain is heterogeneous, and this real-world study showed that a high proportion of patients experienced an interruption of pain management during the 12 months following the onset of the COVID-19 pandemic.